Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Cortes, JE; Feldman, EJ; Yee, K; Rizzieri, DA; Advani, AS; Charman, A; Toal, MJ; Kantarjian, HM

Published Date

  • November 18, 2011

Published In

Volume / Issue

  • 118 / 21

Start / End Page

  • 348 - 348

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Conference Location

  • San Diego, CA

Conference Start Date

  • December 10, 2011

Conference End Date

  • December 13, 2011